The three-layer record
Layer 1
Current roster
One identifiable entry for every current prescription, over-the-counter drug, vitamin, and supplement.
Layer 2
Dated timeline
One row for each administration, change, symptom entry, measurement, lab, or other event.
Layer 3
Question queue
A short list of unresolved questions, kept separate from observations and ready for the prescriber.
Layer 1: build the current roster
FDA guidance says a medication list covers prescription medicines, over-the-counter drugs, vitamins, and supplements. It suggests recording each medicine’s name, strength, purpose, and instructions for when, how, and how much, then updating the list when a prescription, dose, or status changes. [1]
FDA Form 3500 instructions add useful product and use details: product name and strength, manufacturer or compounder, NDC or unique ID and lot when known, dose or amount, frequency, route, treatment dates, indication, product type, and expiration. [2]
Fields for each roster item
- Exact product name; active ingredient if the label shows it
- Strength or concentration exactly as labeled
- Manufacturer, compounder, pharmacy, or other source
- Route, frequency, and clinician-directed instructions copied without calculation
- Current status
- Start and stop dates
- Lot, NDC or unique ID, and expiration if available
- Purpose
- Every prescription, over-the-counter drug, vitamin, and supplement
These fields reflect FDA medication-list and event-reporting guidance. [1] [2]
Layer 2: use one row per event
FDA Form 3500 instructions call for the event date and narrative, relevant tests or labs with dates, product-use details and treatment dates, and the names and therapy dates of other medical products used at the same time. [2] A timeline can keep those details in sequence without turning sequence into a claim of cause.
| Event field | What to preserve |
|---|---|
| Date and time | When the event occurred |
| Exact product | The identifiable product tied to that row |
| Actual vs planned | What actually occurred beside the documented plan |
| Directed change | What changed and who directed it |
| Symptoms | Neutral wording and onset, without assigning cause |
| Labs and measurements | Values copied with dates, units, and source |
| Other products | Other concomitant medical products associated with the event |
| Unresolved question | What still needs clarification |
Use neutral sequence language such as “symptom began at 6:30 p.m.” The timeline records order and context; it does not prove what caused an event.
A “stack” is not one record
A nickname for a group of products can be useful shorthand, but the roster and timeline still need to keep each product identifiable. Otherwise, a changed source, label, strength, status, or date can disappear inside the group name.
The distinction matters for compounded products. FDA says compounded drugs are not FDA-approved and that it does not review their safety, effectiveness, or quality before marketing; FDA also notes that compounded labels may not include important information. [3]
Label-specific example
Why exact names and the full list matter
The current Wegovy label says concomitant use with other semaglutide-containing products or any other GLP-1 receptor agonist is not recommended. It also says Wegovy delays gastric emptying and may affect absorption of concomitant oral medicines. [4]
This is one product-label example, not a universal interaction rule or an interaction screen. It shows why exact product names, active ingredients, all concomitant products, and the applicable label need to remain visible.
Layer 3: keep a prescriber question queue
Keep questions separate from facts already recorded. A short queue makes unresolved issues visible without converting them into conclusions or directives.
- Does any item duplicate or overlap another?
- Which applicable label governs each product?
- Do any oral medicines need special review?
- Which measurements or labs, if any, matter for this specific plan?
- What should trigger contact with the office?
What the tracker cannot do
It cannot clear combinations or interactions.
It cannot select doses or timing.
It cannot prove causality.
It cannot interpret labs or measurements.
It cannot prove a product’s identity or purity.
Keep the full timeline legible
Track multiple compounds in one history
Jabbit supports multiple compounds, schedules and reminders, vial context, site rotation, and injection and progress history. It does not screen interactions or interpret results.
Keep your protocol timeline in JabbitFrequently asked questions
What are the three layers of a multi-compound protocol tracker?
Keep a current roster, a one-row-per-event dated timeline, and an unresolved-question queue together. The roster shows what is current, the timeline preserves what happened, and the queue keeps open questions visible.
Should a peptide stack be logged as one item?
No. Keep every product identifiable by its exact product name and active ingredient when shown, labeled strength or concentration, source, route, frequency, status, and relevant dates. [1] [2]
Can a protocol tracker clear a combination or check interactions?
No. A tracker can organize the record, but it cannot clear combinations or interactions, select doses or timing, prove causality, interpret labs, or prove a product’s identity or purity.
How should symptoms be recorded on the timeline?
Use neutral language and record the symptom and onset without assigning cause. Keep the exact product, what actually occurred, other products, and any dated measurements in the same event row. [2]
Sources opened and checked
- [1]FDA: Create and Keep a Medication List for Your Health.
- [2]FDA: Instructions for Completing Form FDA 3500.
- [3]FDA: Understanding the Risks of Compounded Drugs.
- [4]DailyMed: current Wegovy labeling.
All four sources were opened and checked on July 29, 2026.